EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Measurement of metabolite levels and treatment‐induced changes in hepatic metastases of gastro‐esophageal cancer using 7‐T phosphorus magnetic resonance spectroscopic imaging

Lieke van den Wildenberg iD, Bobby A Runderkamp iD, Leonard W F Seelen, Hanneke W M van Laarhoven iD, Mark W J M Gosselink, Wybe J M van der Kemp iD, Nadia Haj Mohammad, Dennis W J Klomp, Jeanine J Prompers iD

NMR in Biomedicine · 2024

DOI: 10.1002/nbm.5155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, 2024. Verfasst von Lieke van den Wildenberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Liver Neoplasms, Magnetic Resonance Spectroscopy, Esophageal Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: H2020-FETopen:NICI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methods for early treatment response evaluation to systemic therapy of liver metastases are lacking. Tumor tissue often exhibits an increased ratio of phosphomonoesters to phosphodiesters (PME/PDE), which can be noninvasively measured by phosphorus magnetic resonance spectroscopy ( 31 P MRS), and may be a marker for early therapy response assessment in liver metastases. However, with commonly used 31 P surface coils for liver 31 P MRS, the liver is not fully covered, and metastases may be missed. The objective of this study was to demonstrate the feasibility of 31 P MRS imaging ( 31 P MRSI) with full liver coverage to assess 31 P metabolite levels and chemotherapy‐induced changes in liver metastases of gastro‐esophageal cancer, using a 31 P whole‐body birdcage transmit coil in combination with a 31 P body receive array at 7 T. 3D 31 P MRSI data were acquired in two patients with hepatic metastases of esophageal cancer, before the start of chemotherapy and after 2 (and 9 in patient 2) weeks of chemotherapy. 3D 31 P MRSI acquisitions were performed using an integrated 31 P whole‐body transmit coil in combination with a 16‐channel body receive array at 7 T, with a field of view covering the full abdomen and a nominal voxel size of 20‐mm isotropic. From the 31 P MRSI data, 12 31 P metabolite signals were quantified. Prior to chemotherapy initiation, both PMEs, that is, phosphocholine (PC) and phosphoethanolamine (PE), were significantly higher in all metastases compared with the levels previously determined in the liver of healthy volunteers. After 2 weeks of chemotherapy, PC and PE levels remained high or even increased further, resulting in increased PME/PDE ratios compared with healthy liver tissue, in correspondence with the clinical assessment of progressive disease after 2 months of chemotherapy. The suggested approach may present a viable tool for early therapy (non)response assessment of tumor metabolism in patients with liver metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsMagnetic Resonance SpectroscopyEsophageal NeoplasmsStomach NeoplasmsHumansMaleMiddle AgedPhosphorusFemaleAgedMagnetic Resonance Imaging

Stichwörter der Autor:innen

7 Tcancerliver metastasismagnetic resonance spectroscopymembrane turnoverphosphorustreatment response

Substanzen

Phosphorus

Autor:innen und Institutionen

  • Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Surgery, UMC Utrecht Cancer Center, Utrecht, The Netherlands.
  • Sint Antonius Hospital Nieuwegein, Regional Academic Cancer Center Utrecht, Utrecht, The Netherlands.
  • Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Department of Medical Oncology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Lieke van den Wildenberg, Bobby A Runderkamp, Hanneke W M van Laarhoven, Wybe J M van der Kemp, Jeanine J Prompers

Förderung

  • H2020-FETopen:NICI

Zitieren

APA

van den Wildenberg, L., Runderkamp, B. A., Seelen, L. W. F., van Laarhoven, H. W. M., Gosselink, M. W. J. M., van der Kemp, W. J. M., Haj Mohammad, N., Klomp, D. W. J., & Prompers, J. J. (2024). Measurement of metabolite levels and treatment‐induced changes in hepatic metastases of gastro‐esophageal cancer using 7‐T phosphorus magnetic resonance spectroscopic imaging. NMR in Biomedicine. https://doi.org/10.1002/nbm.5155

Vancouver

van den Wildenberg L, Runderkamp BA, Seelen LWF, van Laarhoven HWM, Gosselink MWJM, van der Kemp WJM, et al. Measurement of metabolite levels and treatment‐induced changes in hepatic metastases of gastro‐esophageal cancer using 7‐T phosphorus magnetic resonance spectroscopic imaging. NMR in Biomedicine. 2024. doi:10.1002/nbm.5155

BibTeX
@article{vandenWildenberg2024,
  author = {van den Wildenberg, Lieke and Runderkamp, Bobby A and Seelen, Leonard W F and van Laarhoven, Hanneke W M and Gosselink, Mark W J M and van der Kemp, Wybe J M and Haj Mohammad, Nadia and Klomp, Dennis W J and Prompers, Jeanine J},
  title = {Measurement of metabolite levels and treatment‐induced changes in hepatic metastases of gastro‐esophageal cancer using 7‐T phosphorus magnetic resonance spectroscopic imaging},
  journal = {NMR in Biomedicine},
  year = {2024},
  doi = {10.1002/nbm.5155}
}
Kostenlos starten →